Keyphrases
One Dose
100%
Neutralizing Antibodies
100%
Two-dose
100%
COVID-19
100%
IgG Antibody Response
100%
COVID-19 mRNA Vaccine
100%
MRNA Vaccine
57%
Diagnostic Test
42%
Vaccination
42%
Viral Diagnostics
42%
Vaccine Dose
28%
COVID-19 Diagnosis
28%
BNT162b2
28%
Surrogate Neutralization
28%
MRNA-1273
28%
Northwestern University
14%
Chicago
14%
Hospitalization
14%
Community-based
14%
National Science Foundation
14%
Receptor Binding
14%
Pfizer
14%
Receptor-binding Domain
14%
Revaccination
14%
University Offices
14%
Angiotensin-converting Enzyme
14%
Non-white
14%
Antibody Concentration
14%
IgG Antibody
14%
ACE2 Receptor
14%
Serostatus
14%
Anti-SARS-CoV-2
14%
High Response
14%
Acute Virus
14%
Virus Detection
14%
Non-hospitalized
14%
IgG Test
14%
Serosurvey
14%
IgG Concentration
14%
Antireceptor
14%
Antibody-mediated Neutralization
14%
Spike Receptor Binding Domain
14%
SARS-CoV-2 Spike Receptor Binding Domain
14%
Moderna
14%
Anti-spike
14%
Spike-ACE2 Interaction
14%
Immunology and Microbiology
Neutralizing Antibody
100%
COVID-19
100%
Antibody Response
100%
Neutralization
87%
Receptor Binding
50%
Spike
50%
Severe Acute Respiratory Syndrome Coronavirus 2
37%
Immunoglobulin G Antibody
12%
Immunology
12%
Biochemistry, Genetics and Molecular Biology
Antibody Response
100%
Neutralizing Antibody
100%
Messenger RNA
100%
Receptor Binding
57%
Spike
57%
Binding Domain
42%
SARS Coronavirus
42%
Angiotensin-Converting Enzyme
14%
Antibody Blood Level
14%
Pharmacology, Toxicology and Pharmaceutical Science
mRNA Vaccine
100%
Receptor
100%
Neutralizing Antibody
100%
SARS Coronavirus
75%
Messenger RNA
75%
Dipeptidyl Carboxypeptidase
25%
Immunoglobulin G Antibody
25%